Screener

Eligibility screening

Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in…

Sponsored by Kura Oncology, Inc.Study detailsClinicalTrials.gov

44 US sites in AZ, CA, CO, CT +20

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.